Submit Deal

Submit Deal

Cover Image PROGENICS PHARMACEUTICALS

PROGENICS PHARMACEUTICALS

PROGENICS PHARMACEUTICALS

Summary

Progenics Pharmaceuticals is an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 423 M

Avg. Deal Size£ 423 M

Market Context

Sort

jg

james golden

PROGENICS PHARMACEUTICALS

Manager

1

Deal

£ 423 M

Total Value

mb

mark baker

CEO at PROGENICS PHARMACEUTICALS

Manager

1

Deal

£ 423 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite